Accolade (ACCD)
(Delayed Data from NSDQ)
$4.34 USD
+0.03 (0.70%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $4.33 -0.01 (-0.23%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.34 USD
+0.03 (0.70%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $4.33 -0.01 (-0.23%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
Zacks News
All You Need to Know About Accolade (ACCD) Rating Upgrade to Buy
by Zacks Equity Research
Accolade (ACCD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Why You Should Retain Xerox (XRX) in Your Portfolio Now
by Zacks Equity Research
Xerox's (XRX) bottom line is benefiting from "Project Own It," an enterprise-wide transformation initiative aimed at increasing productivity and operational efficiency.
Reasons Why Waste Connections (WCN) is an Attractive Pick Now
by Zacks Equity Research
Waste Connections (WCN) gains from opportunities in solid waste across its regional footprint.
After Plunging -46.98% in 4 Weeks, Here's Why the Trend Might Reverse for Accolade (ACCD)
by Zacks Equity Research
Accolade (ACCD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
After Plunging -47.01% in 4 Weeks, Here's Why the Trend Might Reverse for Accolade (ACCD)
by Zacks Equity Research
Accolade (ACCD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ManpowerGroup (MAN) Gains on Acquisitions Amid Rising Expenses
by Zacks Equity Research
ManpowerGroup (MAN) is benefiting from strong pricing, cost control and acquisitions.
Accolade (ACCD) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Accolade (ACCD) delivered earnings and revenue surprises of 27.08% and 5.20%, respectively, for the quarter ended May 2024. Do the numbers hold clues to what lies ahead for the stock?
Yext (YEXT) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Yext (YEXT) delivered earnings and revenue surprises of -28.57% and 0.37%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
DocuSign (DOCU) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
DocuSign (DOCU) delivered earnings and revenue surprises of 3.80% and 0.51%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
Accolade (ACCD) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Accolade (ACCD) delivered earnings and revenue surprises of 9.09% and 0.64%, respectively, for the quarter ended February 2024. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Paymentus (PAY): Can Its 7.8% Jump Turn into More Strength?
by Zacks Equity Research
Paymentus (PAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Are Business Services Stocks Lagging Accolade (ACCD) This Year?
by Zacks Equity Research
Here is how Accolade (ACCD) and Palantir Technologies Inc. (PLTR) have performed compared to their sector so far this year.
Does Accolade (ACCD) Have the Potential to Rally 25.58% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 25.6% upside potential for Accolade (ACCD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks.com featured highlights include AxoGen, Western Digital, Accolade and Credo Technology Group
by Zacks Equity Research
AxoGen, Western Digital, Accolade and Credo Technology Group are part of the Screen of the Week article.
4 Top Stocks That Flaunt Solid Earnings Acceleration
by Tirthankar Chakraborty
Invest in stocks such as AxoGen (AXGN), Western Digital (WDC), Accolade (ACCD) and Credo Technology (CRDO) for superb earnings acceleration.
Wall Street Analysts Predict a 26.85% Upside in Accolade (ACCD): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 26.9% upside potential for Accolade (ACCD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Why Accolade (ACCD) Stock Might be a Great Pick
by Zacks Equity Research
Accolade (ACCD) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Will Accolade (ACCD) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Accolade (ACCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Steelcase (SCS) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Steelcase (SCS) delivered earnings and revenue surprises of 76.47% and 0.80%, respectively, for the quarter ended November 2023. Do the numbers hold clues to what lies ahead for the stock?
Is Accolade (ACCD) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Accolade (ACCD) and Adecco SA (AHEXY) have performed compared to their sector so far this year.
Down -31.39% in 4 Weeks, Here's Why Accolade (ACCD) Looks Ripe for a Turnaround
by Zacks Equity Research
Accolade (ACCD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Here's Why Accolade (ACCD) is Poised for a Turnaround After Losing -36.43% in 4 Weeks
by Zacks Equity Research
Accolade (ACCD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Accolade (ACCD) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Accolade (ACCD) delivered earnings and revenue surprises of 23.21% and 2.65%, respectively, for the quarter ended August 2023. Do the numbers hold clues to what lies ahead for the stock?
Skillsoft Corp. (SKIL) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Skillsoft Corp. (SKIL) delivered earnings and revenue surprises of 10% and 0.93%, respectively, for the quarter ended July 2023. Do the numbers hold clues to what lies ahead for the stock?
Braze, Inc. (BRZE) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Braze, Inc. (BRZE) delivered earnings and revenue surprises of 71.43% and 6.12%, respectively, for the quarter ended July 2023. Do the numbers hold clues to what lies ahead for the stock?